A case of PUO in diabetes mellitus

Autor: Shipra Gulati, PK Agarwal, Ambuj Garg, Sunila Jain

Publikováno v: Current Medicine Research and Practice. 12:128

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f70dc9fbeb3b37970040879a9da6259b
https://doi.org/10.4103/cmrp.cmrp_2_22

Observer perception variability in bronchial brush cytology - A statistical analysis

Autor: MM Goel, Sanjay Upreti, Anju Mehrotra, P Nath, PK Agarwal, AN Srivastava, Rajendra Prasad

Publikováno v: Journal of Cytology. 16:75

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::97cb5f8c372ad51b85df3f743228e4d7
https://doi.org/10.4103/0970-9371.237670

Trends in the use of immediate postoperative intravesical chemotherapy following transurethral resection of bladder tumors.

Autor: Dahmen AS; Section of Urology, University of Chicago Medicine, Chicago, IL. Electronic address: aaron.dahmen@uchicagomedicine.org., Nusbaum DJ; Section of Urology, University of Chicago Medicine, Chicago, IL., Lazarovich A; Section of Urology, University of Chicago Medicine, Chicago, IL., Fialkoff J; Section of Urology, University of Chicago Medicine, Chicago, IL., Modi PK; Section of Urology, University of Chicago Medicine, Chicago, IL., Agarwal PK; Section of Urology, University of Chicago Medicine, Chicago, IL.

Publikováno v: Urologic oncology [Urol Oncol] 2024 Oct 22. Date of Electronic Publication: 2024 Oct 22.

Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors.

Autor: Apolo AB; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Girardi DM; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Niglio SA; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Nadal R; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Kydd AR; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Simon N; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Ley L; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Cordes LM; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Chandran E; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Steinberg SM; Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Lee S; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Lee MJ; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Rastogi S; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Sato N; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Cao L; Molecular Targets Core, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Banday AR; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Boudjadi S; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Merino MJ; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Toubaji A; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Akbulut D; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Redd B; Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD., Bagheri H; Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD., Costello R; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Gurram S; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Agarwal PK; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Chalfin HJ; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Valera V; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Streicher H; Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Rockville, MD., Wright JJ; Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Rockville, MD., Sharon E; Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Rockville, MD., Figg WD; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Parnes HL; Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD., Gulley JL; Center for Onco-Immunology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Saraiya B; Genitourinary Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Pal SK; City of Hope Comprehensive Cancer Center, Duarte, CA., Quinn D; Division of Cancer Medicine and Blood Diseases, Department of Medicine, Genitourinary Oncology, Keck School of Medicine, University of Southern California, Los Angeles, CA., Stein MN; Genitourinary Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY., Lara PN; University of California Davis Comprehensive Cancer Center, Sacramento, CA., Bottaro DP; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Mortazavi A; Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University, and the Comprehensive Cancer Center, Columbus, OH.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Sep 01; Vol. 42 (25), pp. 3033-3046. Date of Electronic Publication: 2024 Jul 02.

Assessing travel time performance of multimodal transportation systems using fuzzy-analytic hierarchy process: A case study of Bhopal City.

Autor: Tanwar R; Department of Civil Engineering, Maulana Azad National Institute of Technology Bhopal, 462003, India., Agarwal PK; Department of Civil Engineering, Maulana Azad National Institute of Technology Bhopal, 462003, India.

Publikováno v: Heliyon [Heliyon] 2024 Aug 24; Vol. 10 (17), pp. e36844. Date of Electronic Publication: 2024 Aug 24 (Print Publication: 2024).